BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11345049)

  • 1. Effect of Ukrain on human liver alcohol dehydrogenase activity in vitro.
    Jagiełło-Wójtowicz E; Dudka J; Dawidek-Pietryka K
    Drugs Exp Clin Res; 2000; 26(5-6):337-9. PubMed ID: 11345049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of selected alcohol dehydrogenase inhibitors on human hepatic lactate dehydrogenase activity - an in vitro study.
    Dudka J; Burdan F; Szumilo J; Tokarska E; Korobowicz A; Klepacz R; Gieroba R; Madej B; Korobowicz E
    J Appl Toxicol; 2005; 25(6):549-53. PubMed ID: 16208625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Ukrain on the activities of DNA-nicking enzymes.
    Votrin II; Voltchek IV; Kurochkin SN; Kolobkov SL
    Drugs Exp Clin Res; 2000; 26(5-6):267-73. PubMed ID: 11345037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies concerning the effect of Ukrain in vivo and in vitro.
    Brüller W
    Drugs Exp Clin Res; 1992; 18 Suppl():13-6. PubMed ID: 1305037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective inhibition of in vitro cell growth by the anti-tumour drug Ukrain.
    Hohenwarter O; Strutzenberger K; Katinger H; Liepins A; Nowicky JW
    Drugs Exp Clin Res; 1992; 18 Suppl():1-4. PubMed ID: 1305034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ukrain: a novel antitumor drug.
    Uglyanitsa KN; Nefyodov LI; Doroshenko YM; Nowicky JW; Volchek IV; Brzosko WJ; Hodysh YJ
    Drugs Exp Clin Res; 2000; 26(5-6):341-56. PubMed ID: 11345050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of Ukrain and cyclophosphamide administration on HA-1 murine hepatoma and LS lymphoma on aspartic proteinase cathepsin D.
    Djanayeva SJ; Korolenko TA; Svechnikova IG; Falameyeva OV; Korolenko E; Kaledin VI; Nowicky J
    Drugs Exp Clin Res; 2000; 26(5-6):293-9. PubMed ID: 11345041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of apoptosis in cultured Chinese hamster ovary cells by Ukrain and its synergistic action with etoposide.
    Kurochkin SN; Kolobkov SL; Votrin II; Voltchek IV
    Drugs Exp Clin Res; 2000; 26(5-6):275-8. PubMed ID: 11345038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of Ukrain on the redox processes of hepatocytes.
    Zhalilo LI; Susak YM; Zemskov SV; Susak IA
    Drugs Exp Clin Res; 1996; 22(3-5):189-91. PubMed ID: 8899328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of Ukrain on the nuclear thyroid hormone receptors after short-term gamma-irradiation.
    Luksa-Lichtenthaler GL; Ladutko EI; Nowicky JW
    Drugs Exp Clin Res; 2000; 26(5-6):307-10. PubMed ID: 11345043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chitotriosidase as a new marker of macrophage stimulation in a tumor model treated with cyclophosphamide and Ukrain.
    Korolenko TA; Djanayeva SJ; Falameyeva OV; Wevers RA; Filjushina EE; Buzueva II; Kaledin VI; Sandula J; Nowicky J
    Drugs Exp Clin Res; 2000; 26(5-6):279-83. PubMed ID: 11345039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiomodification effects of Ukrain, a cytostatic and immunomodulating drug, on intracellular glucocorticoid reception during short-term gamma-irradiation.
    Luksa-Lichtenthaeler GL; Ladutko EI; Nowicky JW
    Drugs Exp Clin Res; 2000; 26(5-6):311-5. PubMed ID: 11345044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ukrain (NSC-631570) influences on bone status: a review.
    Jabłoński M
    Drugs Exp Clin Res; 2000; 26(5-6):317-20. PubMed ID: 11345045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutaneous metabolism of glycol ethers.
    Lockley DJ; Howes D; Williams FM
    Arch Toxicol; 2005 Mar; 79(3):160-8. PubMed ID: 15551062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical aspects of cancer treatment and new biochemical mechanisms of the drug Ukrain.
    Uglyanitsa KN; Nefyodov LI; Karayedova LM; Nowicky JW; Brzosko W
    Drugs Exp Clin Res; 2000; 26(5-6):239-47. PubMed ID: 11345031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The dynamics of concentration of the main fluorescent component of Ukrain in the tissues and blood plasma of rats with W-256 tumor after a single intravenous injection.
    Doroshenko YM; Karavay AV; Hodysh YY; Uglyanitsa KN; Nowicky WM; Nefyodov LI
    Drugs Exp Clin Res; 2000; 26(5-6):171-7. PubMed ID: 11345024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A method for determination of Ukrain in blood plasma for monitoring and pharmacokinetic study.
    Doroshenko YM; Hodysh YY; Uglyanitsa KN; Nefyodov LI
    Drugs Exp Clin Res; 2000; 26(5-6):163-70. PubMed ID: 11345023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cystatin C in LS lymphosarcoma and HA-1 hepatoma treated with Ukrain and cyclophosphamide and involvement of apoptosis.
    Korolenko TA; Poteryaeva ON; Djanayeva SJ; Svechnikova IG; Kaledin VI; Timofeyeva OA; Filipenko ML; Nowicky J
    Drugs Exp Clin Res; 2000; 26(5-6):285-92. PubMed ID: 11345040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of the antitumor effect of Ukrain: the role of macrophage secretion of alpha-1-proteinase inhibitor.
    Korolenko TA; Kaledin VI; Svechnikova IG; Li XV; Stashko JF; Ilnitskaya SI; Nikolin VP
    Drugs Exp Clin Res; 1998; 24(5-6):271-6. PubMed ID: 10190086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proapoptotic activity of Ukrain is based on Chelidonium majus L. alkaloids and mediated via a mitochondrial death pathway.
    Habermehl D; Kammerer B; Handrick R; Eldh T; Gruber C; Cordes N; Daniel PT; Plasswilm L; Bamberg M; Belka C; Jendrossek V
    BMC Cancer; 2006 Jan; 6():14. PubMed ID: 16417634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.